ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

van den Elsen, Simone H. J.; Sturkenboom, Marieke G. G.; Akkerman, Onno; Barkane, Linda; Bruchfeld, Judith; Eather, Geoffrey; Heysell, Scott K.; Hurevich, Henadz; Kuksa, Liga; Kunst, Heinke; Kuhlin, Johanna; Manika, Katerina; Moschos, Charalampos; Mpagama, Stellah G.; Munoz Torrico, Marcela; Skrahina, Alena; Sotgiu, Giovanni; Tadolini, Marina; Tiberi, Simon; Volpato, Francesca; van der Werf, Tjip S.; Wilson, Malcolm R.; Zuniga, Joaquin; Touw, Daan J.; Migliori, Giovanni B.
BMJ Open2020DOI: 10.1136/bmjopen-2019-035350
5被引1阅读
引用收藏
分享

摘要

IntroductionGlobal multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain suboptimal. Highly active WHO group A drugs moxifloxacin and levofloxacin show intraindividual and interindividual pharmacokinetic variability which can cause low drug exposure. Therefore, therapeutic drug monitoring (TDM) of fluoroquinolones is recommended to personalise the drug dosage, aiming to prevent the development of drug resistance and optimise treatment. However, TDM is considered laborious and expensive, and the clinical benefit in MDR-TB has not been extensively studied. This observational multicentre study aims to determine the feasibility of centralised TDM and to investigate the impact of fluoroquinolone TDM on sputum conversion rates in patients with MDR-TB compared with historical controls.Methods and analysisPatients aged 18 years or older with sputum smear and culture-positive pulmonary MDR-TB will be eligible for inclusion. Patients receiving TDM using a limited sampling strategy (t=0and t=5hours) will be matched to historical controls without TDM in a 1:2 ratio. Sample analysis and dosing advice will be performed in a centralised laboratory. Centralised TDM will be considered feasible if >80% of the dosing recommendations are returned within 7days after sampling and 100% within 14 days. The number of patients who are sputum smear and culture-negative after 2months of treatment will be determined in the prospective TDM group and will be compared with the control group without TDM to determine the impact of TDM.Ethics and disseminationEthical clearance was obtained by the ethical review committees of the 10 participating hospitals according to local procedures or is pending (online supplementary file 1). Patients will be included after obtaining written informed consent. We aim to publish the study results in a peer-reviewed journal.Trial registration numberClinicalTrials.gov Registry (NCT03409315).

学科与关键词

关键词
tuberculosisclinical pharmacologyorganisation of health servicesinfectious diseases
相关
加载中…
  • A Review of Clinical Pharmacokinetic and Pharmacodynamic Relationships and Clinical Implications for Drugs Used to Treat Multi-drug Resistant Tuberculosis
    Wilby, Kyle John*; Hussain, Farhat NazEUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45(3): 305-313.被引 5
  • Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
    Thu, Nguyen Quang; Tien, Nguyen Tran Nam; Yen, Nguyen Thi Hai; Duong, Thuc-Huy; Long, Nguyen Phuoc*; Nguyen, Huy Truong*Journal of Pharmaceutical Analysis, 2024, 14(1): 16-38.被引 2
  • Quantitative assessment of the activity of antituberculosis drugs and regimens
    Chirehwa, Maxwell T.*; Velasquez, Gustavo E.; Gumbo, Tawanda; McIlleron, HelenExpert Review of Anti-Infective Therapy, 2019, 17(6): 449-457.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
BMJ Open
发表日期
2020
卷期
第 10 卷, 第 6 期
页码
e035350
DOI
10.1136/bmjopen-2019-035350
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE

作者

  • v

    van den Elsen, Simone H. J. (第一作者)

  • S

    Sturkenboom, Marieke G. G.

查看全部 26 位作者收起作者
  • A

    Akkerman, Onno

  • B

    Barkane, Linda

  • B

    Bruchfeld, Judith

  • E

    Eather, Geoffrey

  • H

    Heysell, Scott K.

  • H

    Hurevich, Henadz

  • K

    Kuksa, Liga

  • K

    Kunst, Heinke

  • K

    Kuhlin, Johanna

  • M

    Manika, Katerina

  • M

    Moschos, Charalampos

  • M

    Mpagama, Stellah G.

  • M

    Munoz Torrico, Marcela

  • S

    Skrahina, Alena

  • S

    Sotgiu, Giovanni

  • T

    Tadolini, Marina

  • T

    Tiberi, Simon

  • V

    Volpato, Francesca

  • v

    van der Werf, Tjip S.

  • W

    Wilson, Malcolm R.

  • Z

    Zuniga, Joaquin

  • T

    Touw, Daan J.

  • M

    Migliori, Giovanni B.

  • A

    Alffenaar, Jan-Willem (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417